Page last updated: 2024-08-17

phthalimide and Leukemia, Promyelocytic, Acute

phthalimide has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bradner, JE; Buckley, DL; Dhe-Paganon, S; Paulk, J; Roberts, JM; Souza, A; Winter, GE	1

Other Studies

1 other study(ies) available for phthalimide and Leukemia, Promyelocytic, Acute

Article	Year
DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science (New York, N.Y.), 2015, Jun-19, Volume: 348, Issue:6241 Topics: Adaptor Proteins, Signal Transducing; Animals; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Crystallography, X-Ray; Disease Models, Animal; Drug Design; Leukemia, Promyelocytic, Acute; Ligands; Mice; Molecular Targeted Therapy; Nuclear Proteins; Peptide Hydrolases; Phthalimides; Protein Stability; Protein Structure, Tertiary; Proteolysis; Tacrolimus Binding Protein 1A; Thalidomide; Transcription Factors; Ubiquitin-Protein Ligases	2015

Article

Year

DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation.

Science (New York, N.Y.), 2015, Jun-19, Volume: 348, Issue:6241

Topics: Adaptor Proteins, Signal Transducing; Animals; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Crystallography, X-Ray; Disease Models, Animal; Drug Design; Leukemia, Promyelocytic, Acute; Ligands; Mice; Molecular Targeted Therapy; Nuclear Proteins; Peptide Hydrolases; Phthalimides; Protein Stability; Protein Structure, Tertiary; Proteolysis; Tacrolimus Binding Protein 1A; Thalidomide; Transcription Factors; Ubiquitin-Protein Ligases

2015